introduction

Our Founders have worked for 10 years to create an efficient way to discover new chemistry, naturally made by microbes.

While our vision is that we will discover all undiscovered compounds produced by microbes, and make them accessible to life science R&D organizations around the world, we are happy to announce a great example of a natural product. We plan to concentrate on developing and licensing a new, natural herbicide. Our labs and collaborating labs hope to be able to accomplish many of the late development de-risking activities while our collaborator will concentrate on the larger

We envision licensing our lead natural herbicide to an Agriculture company such as: → Valent(Sumitomo), Bayer, FMC, UPL, Corteva, Syngenta, NuFarm, ADAMA

success to date

  • Seven peer-reviewed publications identifying new molecules discovered using the MGx platform.
  • Investigated/discovered new molecules for clients in the agriculture and animal health industries (Corteva, Valent, Elanco).
  • $400k angel investment in 2020.
  • License for MGX-1001, a promising new herbicide with the potential to be the first new mechanism of action broad spectrum herbicide in 35 years (US Provisional Patent Applications #63/075138 and #63/181,745, PCT Patent Application #PCT/US2021/048904).
  • One of six finalists in the 2022 $1M Radicle Growth-UPL Challenge.
  • Out of 580 entrants, chosen for 1st Cohort HudsonAlpha AgTech Accelerator 2022, along with $100K convertible note
  • Out of 4500 entrants, chosen as finalist in Hello Tomorrow Global Deep Tech Challenge.
  • We now have two top 10 Ag Companies interested in testing/developing our herbicide.

problem

The key problem we are solving is: Herbicide-Resistant Weeds.

30% of crop losses each year are due to weeds. It is estimated that global crop yield lost to weeds could feed 1 billion people every year! Most of those losses are due to herbicide resistant weeds - due to overuse of current herbicides and lack of new mechanisms of action. Most herbicides on the market have seen some kind of resistance in the targeted weeds.

Yet, no broad-spectrum herbicide with a new mechanism of action has been discovered in over 35 years! This lack of innovation is incredible and hurts the farmers around the world.

solution

The MGx platform technology discovers new chemistry by harnessing the power of the world’s best chemists: microbes. Microbes have been creating and modifying chemicals to do specific tasks for over 4 billion years.

Regarding our lead molecule, we call it MGX 1001, we discovered that the bacteria responsible for the disease - onion center rot - actually produces a natural chemical that we have tested and are now developing into a broad-spectrum herbicide. It appears to have a new mechanism of action. U.S. Provisional Patent Application No. 63/181,745 and U.S. 63/075,138 - Licensed from the University of Illinois in May, 2022.

In the greenhouse test, January 2022, we found good activity against several important weeds. Below is an example of how it performed on an extremely harmful weed, Horseweed (erigeron) - note: this species of horseweed is especially resistant to glyphosate (RoundUp), the most popular herbicide in the world. 10 years to develop the optimal method for exploring and finding new naturally made chemicals.

MGX 1001 clearly has a herbicide activity against this weed while RoundUp had almost no impact at all. A herbicide with this effectiveness against herbicide resistant weeds will help farmers around the world control weeds, use less herbicide, and increase their crops’ yield.

frequently asked questions

What does your company do?
We aim to deliver Nature’s solutions to the world’s farmers. We do this by using cutting edge scientific breakthroughs in genomics and metabolomics to identify brand new chemicals made by bacteria and fungi. Our lead molecule is a natural herbicide with the ability to defeat many herbicide resistant weeds.
Why did you choose this idea?
We believe that Nature holds the solutions to many of the world’s problems. Many problems require chemicals with a focus and complexity that are hard to imagine or create artificially. But nature has been working on its chemistry for billions of years.
In five years, where do you envision your company?
We envision MicroMGx as a lead discovery company for agriculture crop protection products. Our key license deal in 2025 we hope will have opened the doors for much more discovery work in Crop Protection. Our herbicide, MGX 1001 may be talked about as the next great herbicide and many may be trying to follow up with products that focus on this new biological target. Following that, we plan on doing the same in the pharmaceutical industry.
Why is your team uniquely qualified to solve this problem?
Our talented team has been focused on natural product discovery from the beginning. Northwestern University Professors Neil Kelleher and Regan Thomson and University of Illinois at (U-C) Professor William Metcalf integrated their world-class research in mass spectrometry, organic synthesis, and genomics, respectively. Our CSO has been focused on optimizing large scale natural product discovery since 2010. Our CEO has been successfully leading teams and organizations for 4 decades, with both pharma and agriculture R&D experience. We have the science, the location, the network and will soon have a top 10 Ag Collaborator to ensure our success.

business model

MicroMGx is a discovery and licensing company.

Our Process:

  1. Discover new molecules made by microbes using the MGx discovery platform.
  2. Test for bioactivity in crop protection.
  3. Patent the novel molecule and its specific applications (herbicide, fungicide, insecticide).
  4. Find collaborator(s).
  5. License our new molecule to uniquely qualified Global Ag company to develop and commercialize.

Using the MGx platform, we aim to discover new molecules at an unprecedented rate and hope to give the world access to natural medicines and agricultural products still waiting to be discovered.

Licensing would involve an upfront fee to MicroMGx, milestone payments once a customer successfully reaches a development milestone with our chemical, and then, once launched, royalties may flow back to MicroMGx. 

market

The crop protection market (TAM) includes herbicides, insecticides, fungicides, and nematicides. Herbicides (SAM) are mostly generic, with no new mechanism of action in over 30 years. The market (farmers) are hungry for a herbicide that is effective against herbicide-resistant weeds. The top herbicides are currently bringing in $2B - $8B. By 2030, this may be a very conservative range for a disruptive herbicide.

team

William Metcalf, PhD
Chairman/Co-Founder
The G. William Arends Professor in Molecular and Cellular Biology and Professor of Microbiology at the University of Illinois at Urbana-Champaign. His research focuses on the complex chemistry that bacteria perform, including the biogenesis of methane and specialized natural products. Prof. Metcalf advises MicroMGx on the use of comparative genomics to identify the regions of the bacterial genome that are responsible for specialized metabolism, and on the use of advanced genome sequencing technologies.
Neil L. Kelleher
Director/Co-Founder
Neil L. Kelleher is the Walter and Mary Elizabeth Glass Professor of Chemistry, Molecular Biosciences, and Medicine at Northwestern University. Neil’s research focuses on the use of mass spectrometry for applications ranging from proteomics to natural products chemistry. Prof. Kelleher is also an experienced entrepreneur; he has founded three other companies, including the successful software company, Proteinaceous, and Integrated Protein Technologies which provides cutting-edge devices for protein sample preparation. Neil is a co-founder of MicroMgx and advises on business and technology development, especially the integration of mass spectrometry and informatics into MicroMGx’s workflows.

Regan Thomson
Director/Co-Founder
A Professor of Chemistry at Northwestern University. His research pushes the boundaries of reaction design and applies it to drive the synthesis of complex biologically active molecules. As a Co-Founder and member MicroMGx’s board of directors, his insight as a synthetic organic chemist will guide the development of synthetic natural product analogs with improved activity and selectivity. The role of chemical synthesis in the commercialization of natural products with therapeutic activity is especially important because of current intellectual property policy, which severely limits protections on materials and compounds derived directly from nature.
Jack M. Kloeber, PhD
CEO/CFO
Educated in the fields of Decision Analytics, Industrial Engineering, Simulation and Optimization. After teaching Mathematics at USMA, West Point, NY, and 6 years of Graduate level Operations Research at the Air Force Institute of Technology, he retired from the US Army as an LTC and joined Bristol-Myers Squibb as Head of Portfolio Management. He moved to Johnson & Johnson Pharmaceuticals and held the same position for 5 years. Jack became a partner/owner of a successful consulting company Kromite LLC, where he focused on R&D decision-making for 12 years. He joined MicroMGx as CEO bringing experience in running an analytics consulting company and working with executives in pharmaceuticals, government, and agriculture industries.

Anthony Goering, PhD
CSO/COO
Anthony is trained in the fields of natural product discovery and synthetic biology. He performed his graduate research in the laboratory of Professor Neil Kelleher as part of the collaborative team that created metabologenomics, which is now one of MicroMGx’s core technologies. Anthony was employee #1 at MicroMGx. As the chief scientific officer of MicroMGx, he oversees the continued development of metabologenomics, as well as its application to guide and scale the discovery of new, bioactive natural products.
Rajmony Pannu, MD
Director
A practicing vascular specialist in Westerville, OH. He is one of a select few specialists in the country to have board certification in both vascular medicine and endovascular medicine. While an extremely talented physician, Raj is also an active entrepreneur and brings to the MicroMGx Board a keen entrepreneurial mind, combining successful risk-taking, business acumen, and a flair for healthcare marketing.

Use of Proceeds


If the offering's maximum amount of $1,069,998 is raised:

UseValue% of Proceeds
Compensation for managers$136,56812.8%
Unallocated Funds$0less than 0.1%
Platform Costs$600,00056.1%
Testing MGX 1001$150,00014.0%
Rent$36,0003.4%
Structure Isolation$60,0005.6%
Additional Equipment$35,0003.3%
Intermediary fees$52,4304.9%

Terms

This is an offering of Common Stock, under registration exemption 4(a)(6), in MicroMGx, Inc., doing business as MicroMGx Inc. This offering must raise at least $10,000 by April 21, 2023 at 9:59pm ET. If this offering doesn’t reach its target, then your money will be refunded. MicroMGx Inc may issue additional securities to raise up to $1,069,998, the offering’s maximum.

If the offering is successful at raising the maximum amount, then the company’s implied valuation after the offering (sometimes called its post-money valuation) will be:

5,082,726 shares
×
$2.37 per share
$12,046,061implied valuation

Pitch Deck

Financials

MicroMGx Inc’s official name is MicroMGx, Inc., so that’s the name that appears in the statements below.

These financial statements have been reviewed by an independent Certified Public Accountant.

SEC Filings

The Offering Statement is a formal description of the company and this transaction. It’s filed with the SEC to comply with the requirements of exemption 4(a)(6) of the Securities Act of 1933.

We’re also required to share links to each of the SEC filings related to this offering with investors.

Understand the Risks

Be sure to understand the risks of this type of investment. No regulatory body (not the SEC, not any state regulator) has passed upon the merits of or given its approval to the securities, the terms of the offering, or the accuracy or completeness of any offering materials or information posted herein. That’s typical for Regulation CF offerings like this one.

Neither Netcapital nor any of its directors, officers, employees, representatives, affiliates, or agents shall have any liability whatsoever arising from any error or incompleteness of fact or opinion in, or lack of care in the preparation or publication of, the materials and communication herein or the terms or valuation of any securities offering.

The information contained herein includes forward-looking statements. These statements relate to future events or to future financial performance, and involve known and unknown risks, uncertainties, and other factors, that may cause actual results to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties, and other factors, which are, in some cases, beyond the company’s control and which could, and likely will, materially affect actual results, levels of activity, performance, or achievements. Any forward-looking statement reflects the current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. No obligation exists to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

More Info

Updates

  • Sep 1, 2023
  • Apr 22, 2023
    Primary offering finalized, selling 52,535 shares
    Sold 52,535 shares at $2.37 for a total of $124,507.95
  • Apr 21, 2023
    **Thank you to all of our 67 investors** Today...

    Thank you to all of our 67 investors Today is our last day to invest - the last 45 days have been inspiring. We will keep you all up to date with events and milestones at MicroMGx. Our focus now is to continue trials for our herbicide - mgx 1001 - and find co-developers. We should start our next trials by the end of May. Your investments have these trials possible, as well as applying for patents in 35 major countries around the world .

    Original HudsonAlpha Agtech Accelerator announcement
  • Apr 17, 2023
    **Mexico will be banning Glyphosate (RoundUp)...

    Mexico will be banning Glyphosate (RoundUp) starting in March 2024. Why is this important? As key herbicides become banned, they leave a gap in weed control. Farmers around the world who are already searching for solutions to the herbicide resistance problem (in this case Mexico) will be looking for other herbicides to fill the gaps. A naturally produced, broad spectrum herbicide that can defeat weeds, even those that are currently resistant to Glyphosate, could be huge. Our herbicide is being developed at just the right time to help farmers around world.

    Article RE: Banning Glyphosate in Mexico
  • Apr 14, 2023
    We just returned from a trip to Lincoln...

    We just returned from a trip to Lincoln Nebraska where we met with Investors (Invest Nebraska), Accelerators, Entrepreneurial Centers (The Combine) and (Engler Entrepreneurship Center) and a brilliant weed scientist who is helping us obtain a grant from the State of Nebraska to test how broad a spectrum of weeds our herbicide will control. We saw their greenhouses, collections of weed seeds and crop seeds and started a search for an employee in Nebraska. What a hotbed of agricultural Know How, startup savvy leaders, centers with funding, and like-minded entrepreneurs. If all works out, we will be starting a trial by June in Lincoln. Everyone there is excited about developing a naturally made herbicide.
    For several reasons, we have extended this crowdfunding effort one more week. We broke through the $100,000 barrier and are headed toward $150,000!

  • Apr 13, 2023
  • Apr 6, 2023
    **Targeted Question:** We are 8 days away from...

    Targeted Question: We are 8 days away from our close. 45 investors have decided that MicroMGx is a good investment and we thank all 45 of you and are continuing to work to ensure this is one of your best investments. Your investments have ranged from $100 to over $20,000 and the average investment has been $1,900.

    There are 35 interested investors who have not yet decided to invest in MicroMGx. Our targeted question is this: What information do you need to make your decision to invest in us? What question still needs to be answered? Feel free to put your question in the Discussion area or write to me directly at j-kloeber@micromgx.com.

  • Apr 6, 2023
    Hi Investors, a company we all know, Bayer AG,...

    Hi Investors, a company we all know, Bayer AG, (recently merged with Monsanto) published a very relevant article about a new herbicide. They have combined three different mechanisms of action into one herbicide to overcome the growing problem of herbicide resistance. We think this is admirable, and about all you can do when you do not have new mechanisms of action. MicroMGx has a new, naturally made new mechanism of action herbicide. Just think how many new products will be made by combining our new herbicide with others.

    Bayer introduces a multi-mechanism of action herbicide.
  • Apr 4, 2023
    Thank You Friends, Family, Colleagues, and...

    Thank You Friends, Family, Colleagues, and Natural Product enthusiasts for your continued confidence and investment in MicroMGx where we will “Deliver Nature’s solutions to the world’s farmers”. We are heartened by the activity - in the past three weeks, the total investment has jumped nearly 90% , allowing us to conduct more testing of our herbicide and improvement of the fermentation process.

    Two potentially significant investors have indicated they needed more time. Therefore, instead of closing on March 31st, we have extended the crowdfunding effort until April 14th. Every dollar invested will go into further development (of our herbicide) and into strengthening our patent position - 35 countries will have patents pending by the end of April - greatly increasing the value of your investment! Spread the word! Let your neighbors, friends, and colleagues know that MicroMGx is working towards bringing naturally made herbicides to the market - to help farmers feed more people.

  • Mar 30, 2023
  • Mar 29, 2023
    We are excited! 11 new investors in the past...

    We are excited! 11 new investors in the past week, $28,000 invested since Demo Day! Two days left to invest in MicroMGx using this crowdfunding platform. Our new website is redesigned and up and running. Check it out.

    New Website for MicroMGx
  • Mar 27, 2023
    Our last week of crowdfunding! MicroMGx...

    Our last week of crowdfunding! MicroMGx crowdfunding will be ending on March 31st. We have seen a very good trending with more activity and larger average investments over the last few weeks. We think Demo Day last Wednesday helped explain our company, our team, our platform, and especially our naturally produced herbicide. If you missed the demo day, we have put the link to it below. MicroMGx was first, so just click and watch! One investor said that he had trouble on his computer getting the video - so he just listened and after 15 minutes, thought it was a no brainer and invested. We have been working hard to be clear, concise and logical about our company. Any investment made this week will go right into further development of our herbicide to include conducting toxicology test and examine which crops will tolerate our herbicide.

    MicroMGx Demo Day
  • Mar 27, 2023
    We wanted to post this new release from Plug...

    We wanted to post this new release from Plug and Play Technology Center, one of the most active Venture Capital firms in the country. They have announce their selections for this year’s AgTech Accelerator - and MicroMGx has been selected. Our Showcase will be in June in Topeka, Kansas.

    PlugNPlay Selects MicroMGx for 7th AgTech Accelerator
  • Mar 22, 2023
    Today is Demo Day! Be sure to register for...

    Today is Demo Day! Be sure to register for today’s webinar. MicroMGx’s CEO, Jack Kloeber, will be updating everyone and answering YOUR questions! Remember to register and then join right at 4pm edt/ 3pm cdt / 1pm pdt because MicroMGx is the first company of the three companies presenting. MicroMGx will conclude by 4:20pm. Here is the link https://us06web.zoom.us/webinar/register/1116789045159/WN_erHXbW7PSZ2fAjPMZNazqQ

    See you there.

    Demo Day - Register now
  • Mar 20, 2023
    We received exciting news this weekend. Plug N...

    We received exciting news this weekend. Plug N Play AgTech Program had already placed us in their Top 50 AgTech startups in February. We competed last week and just learned that we were selected to be part of their AgTech accelerator program, with a Showcase built for presenting to and finding investors - 14-15 June, in Topeka, Kansas. We are very happy about this selection - not just as validation of how we are building our company, but as a springboard in funding our Seed Round of VC funding. I will have more information about this program for our Demo Day - March 22 (this Wednesday) at 4pm edt/ 3pm cdt. I hope you can attend.

    Learn, ask, listen to MicroMGx Demo Day
  • Mar 15, 2023
    Dear Supporters, We want to express our deepest...

    Dear Supporters, We want to express our deepest gratitude for your critical investment during our crowdfunding campaign for MicroMGx. Thanks to your support, we were able to produce enough of our experimental natural herbicide (mgx 1001) to allow more potential collaborators to test and see for themselves the effectiveness of mgx 1001 against herbicide resistance weeds. Your belief in our vision has been truly humbling and impactful. Many do not realize that a small amount of funds can make such a huge difference in the success of a startup – but clearly you do. We will keep you updated on our progress and developments, knowing that you and we are aligned on two important objectives - 1) to help the world’s farmers produce more with less, and 2) to be so successful as a company that you will realize a huge return on your investment. The MicroMGx Team.

  • Mar 14, 2023
    Silicon Valley Bank's collapse has been in the...

    Silicon Valley Bank’s collapse has been in the news constantly over the past 4 days. I wanted to tell all of our investors that every penny invested in MicroMGx is secure. While NetCapital did use SVB for its escrow accounts, only $1000 of our investors’ money is currently in escrow. Netcapital’s MicroMGx escrow account is guaranteed up to $250,000 so every penny is guaranteed by the FDIC. The rest of the total investment has already been received by MicroMGx and has been used to improve our methods for producing our experimental herbicide and provide more herbicide for 3rd party testing. Feel free to ask any questions, preferably on our Q&A space on this website, so that everyone can see our responses.

  • Feb 22, 2023
    Hello Fellow and Future Investors in MicroMGx....

    Hello Fellow and Future Investors in MicroMGx. We recently started a 2-3 month fermentation scale up effort. When completed, it will be a big milestone for us - ensuring collaborators that our herbicide cost of goods will be within the bounds of profitability. Integrated Bioprocessing Research Lab (IBRL) is assisting us utilizing their 500 liter fermentation tank.

    We are also only two weeks away from the global challenge and competition in Paris, March 8-10 - one of 6 Finalists in the Agriculture and Food track. If we win the track competition we will compete for the grand prize. I will certainly keep you posted. The international exposure and potential prize money will help us continue our development and find Venture Capitalists. All of this will help increase the value of MicroMGx, increasing your investment, and driving us forward to helping the world’s farmers. They are clambering for new herbicides.

    Our International Competition in Paris
  • Feb 15, 2023
  • Feb 13, 2023
    Hello Current and Future Investors. It is an...

    Hello Current and Future Investors. It is an exciting day as we roll out our updated strategic focus. I am positive our current investors will see the wisdom in our approach and new investors will be even more motivated to be part of our company. The bottom line is: We are going to be laser focused on finding a partner and then licensing our lead product - a naturally made herbicide with huge potential to combine with or even replace some of the well known herbicides on the market. Our story is simple - weeds are causing more and more damage every day around the world. Agriculture Companies have not launched a new mechanism of action herbicide in over 30 years. We believe we have one! Have fun reading about our herbicide and ask any questions you want - we will try to respond very quickly. Come on aboard!

  • Jan 25, 2023
    MicroMGx is excited to announce that we have...

    MicroMGx is excited to announce that we have been chosen to be Finalists in the Hello Tomorrow Global Deep Tech Challenge. Only 70 companies were chosen out of 4000+ entrants. This means our CEO will be on stage in Paris, March 9-10, in front of about 400 global investors. This should be an excellent opportunity to showcase our unique method for discovering new molecules and brag about our natural herbicide - mgx 1001 - and how it may be the first new mechanism of action broad-spectrum herbicide in 35 years. We believe this event could be a springboard towards growth and finding more collaborators and more investors. We will keep you informed! Please check out the link below and look at the Food and Agriculture Track.

    Read Official Selection as a Finalist
  • Jan 25, 2023
  • Nov 25, 2022
    As CEO of MicroMGx, I wanted to let our...

    As CEO of MicroMGx, I wanted to let our investors and future investors know that MicroMGx has been selected as a semi-finalist in the Hello Tomorrow Global Challenge. Attached is the letter. This Global Challenge is focused on Deep Technology that has the potential to impact humanity on a large scale. A link to the overall organization is also included below.

    We are honored to have been selected and will find out if we have made the finals in January 2023, but have already been given tickets to the three-day, nationally-supported Deep Technology exposition in March 2023, Paris France.

    Over 4000 companies from around the world applied and we are excited to be considered one of the top companies.

    While we have ups and downs, good days and bad days, we all know and are constantly reminded by others that we have something special at MicroMGx. Thank you all for believing in us.

    Read Official Selection and InvitationMicroMGx 2023 Hello Tomorrow Global Summit Invitation.pdf
  • Oct 27, 2022
  • Oct 23, 2022
    We at MicroMGx are very happy and proud to...

    We at MicroMGx are very happy and proud to announce that the world famous HudsonAlpha Institute’s AgTech Accelerator (HAAA) has chosen MicroMGx to be one of only 5 startup companies (out of 580 applicants) for their inaugural cohort. For the next 8 weeks, our CEO (Jack Kloeber) and CSO (Anthony Goering) will be working intensely with HAAA’s network of scientists, entrepreneurs, marketers, and investors to “accelerate” our growth and readiness for investment. This selection also involves an investment of $100,000 in our company to help us concentrate on growth and to indicate their commitment to our vision. See the official announcement here.

    HudsonAlpha's Official News Release and investment in MicroMGx
  • Oct 13, 2022
    The leadership team at MicroMGx would like to...

    The leadership team at MicroMGx would like to thank the growing number of investors and the growing size of the investment (over $1000 per investor). There are twice as many interested potential investors following our company, compared to just the end of September. We have easily passed the first milestone of $10,000 and are building momentum to reach higher totals and higher average investment to help us quickly expand and succeed.

    Whether you are a large or small investor in MicroMGx, we appreciate your faith in us and our vision. We trust you share our belief that Nature has many new chemicals just waiting to be discovered through our MGx platform. MicroMGx aims to provide access to those valuable chemicals to companies large and small.

  • Sep 22, 2022
    It is starting to get exciting! I have...

    It is starting to get exciting! I have received many questions regarding the size of the investment that is permitted. I have also been approached by a west coast VC and an accelerator about joining the crowdfunding effort. Many questions because many people are checking us out. This is good news.

    Let me clear up the one common question. The minimum investment is NOT $10,000. The minimum allowable investment is only $99.54. That should help with the decisions of many who want to invest $3000 or $5000.

    Please continue to ask or send questions in. I will personally answer every question, whether it is through this announcement method or via email to you.

  • Sep 14, 2022
    We have just started on this 2 month journey to...

    We have just started on this 2 month journey to reach our target of $1M by November. Most investors need some time to read about our fantastic company, consider the risks vs the huge upside of discovering many natural chemicals to solve some of our biggest problems, and then talk it over with others. But 4 investors have already jumped in to declare their belief in our mission. Thank you for being the FIRST FOUR!

  • Sep 2, 2022
    Primary offering of 451,476 shares at $2.37
  • Sep 2, 2022

Ask a Question

Proofread your comment before submitting: once it's posted, you can’t edit or delete it. Investors are advised to review our Discussion Board Policy before submitting a comment. For the fastest help with the web site, email help@netcapital.com instead of commenting.

Looking to raise capital?
We can help turn your friends, family and customers into investors.

Learn more

Interested in more investment opportunities?
Browse all offerings currently available.

See more